Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,170 | 7,401 | 8,095 | 14,379 | 29,717 |
| Marketable Securities | 13,041 | 13,762 | 15,373 | 11,979 | 910 |
| Other current assets | 643 | 282 | 320 | 377 | 391 |
| TOTAL | $19,854 | $21,445 | $23,788 | $26,735 | $31,018 |
| Non-Current Assets | |||||
| PPE Net | 59 | 66 | 69 | 76 | 24 |
| Investments And Advances | 0 | 2,352 | 3,967 | 5,008 | 5,306 |
| Other Non-Current Assets | 676 | 766 | 855 | 816 | 580 |
| TOTAL | $735 | $3,184 | $4,891 | $5,900 | $5,910 |
| Total Assets | $20,589 | $24,629 | $28,679 | $32,635 | $36,928 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 980 | 1,205 | 1,141 | 760 | 1,753 |
| Accrued Expenses | 1,538 | 1,191 | 1,015 | 937 | 591 |
| TOTAL | $2,518 | $2,396 | $2,156 | $1,697 | $2,344 |
| Non-Current Liabilities | |||||
| TOTAL | $35 | $39 | $43 | $47 | $N/A |
| Total Liabilities | $2,553 | $2,435 | $2,199 | $1,744 | $2,344 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43 | 42 | 42 | 42 | 42 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -116,849 | -112,511 | -108,267 | -103,608 | -99,714 |
| Other shareholders' equity | -9 | -19 | -6 | 13 | 6 |
| TOTAL | $18,036 | $22,194 | $26,480 | $30,891 | $34,584 |
| Total Liabilities And Equity | $20,589 | $24,629 | $28,679 | $32,635 | $36,928 |